POLISCOPE
Back to bills
Part ofHealth →

The civic record

Read. Follow. Verify.
Passed

Montana Legislature requests interim study on COVID-19 medical response and treatments

Original title: Interim study of the medical response to COVID-19

Last action · May 23, 2025: (S) Died in CommitteeSponsor: Barry Usher

Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Would Do

Montana lawmakers direct an interim committee or legislative staff to study the short-term and long-term effects of federal COVID-19 medical responses, including vaccines, remdesivir, dexamethasone, and ivermectin, with final results reported to the 70th Legislature by September 15, 2026.

Why it matters

Directs state legislative resources and interim committees to review past pandemic medical guidelines, federal treatment incentives, and the outcomes of the .

Who It Would Affect

Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.

Directly affected

Montana Legislature

Receives the final study results and recommendations prior to the 70th Legislature.

Directly affected

Legislative Council

Tasked with designating an appropriate interim or statutory committee or directing staff resources to conduct the study.

Key Facts

  • The resolution requests an interim committee or staff review of the short-term and long-term effects of COVID-19 vaccines, remdesivir, dexamethasone, and other questionable drugs and treatments.
  • The study is mandated to examine the benefits of ivermectin as a treatment for COVID-19.
  • The study will examine outcomes of the Montana Right to Try Act regarding experimental treatments for active infections, long COVID, and mitigating impacts of vaccines and federally recommended treatments.
  • All aspects of the study must be concluded prior to September 15, 2026.
Show all 5 facts
  • Final results, findings, conclusions, comments, or recommendations must be reported to the 70th Legislature.

Frequently Asked Questions

What topics will the interim study cover regarding COVID-19?
The study will review the effects of COVID-19 vaccines, remdesivir, dexamethasone, other treatments, the benefits of ivermectin, and outcomes under the for long COVID and vaccine mitigation.
When must the study be completed?
All aspects of the study must be concluded prior to September 15, 2026, and reported to the 70th Legislature.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Where This Stands

Currently passed chamber. The next step in the legislative lifecycle is Law.

Procedural history

17 actions
  1. May 23, 2025SenateCommittee
    (S) Died in Committee
  2. Apr 24, 2025Senate
    (S) Motion
  3. Apr 23, 2025SenateCommittee
    (S) Tabled in Committee
  4. Apr 23, 2025Senate
    (S) Hearing
  5. Apr 23, 2025SenateCommittee
    (S) Referred to Committee
  6. Apr 22, 2025Senate
    (S) 1st Reading
Show 11 earlier actions
  1. Apr 22, 2025SenateIntroduced
    (S) Introduced
  2. Apr 22, 2025House
    (LC) Draft Delivered to Requester
  3. Apr 22, 2025House
    (LC) Draft Ready for Delivery
  4. Apr 21, 2025House
    (LC) Draft in Assembly
  5. Apr 21, 2025House
    (LC) Draft in Final Drafter Review
  6. Apr 21, 2025House
    (LC) Draft in Input/Proofing
  7. Apr 18, 2025House
    (LC) Draft in Edit
  8. Apr 17, 2025House
    (LC) Draft in Legal Review
  9. Apr 8, 2025House
    (LC) Draft Taken Off Hold
  10. Nov 11, 2024House
    (LC) Draft On Hold
  11. Nov 11, 2024House
    (LC) Drafter Assigned

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Connected Entities

Montana Right to Try Act, 70th Legislature, Legislative Council and 1 more
otherMontana Right to Try Act“Statute examined for experimental and innovative treatments”Map →
Organization70th Legislature“Body to receive the final results of the study”Map →
OrganizationLegislative Council“Assigned to designate an interim committee or direct staff resources”Map →
locationMontana“State legislature commissioning the study”Map →

Sources

Open source document

bills.legmt.gov

Analysis Score

0–100
  • Significance35
    How much this matters to a regular citizen
  • Controversy65
    Intensity of disagreement among stakeholders
  • Entertainment10
    Compellingness for a non-policy-wonk reader
  • Buzz20
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record